Prakash Raman

Prakash Raman

Director/Board Member at BLACK DIAMOND THERAPEUTICS, INC.

Net worth: 94 582 $ as of 31/08/2026

56 year
Health Technology
Commercial Services
Consumer Services

Profile

Dr. Prakash Raman is an Independent Director at Olema Pharmaceuticals, Inc., a Chief Executive Officer at Indupro, an Independent Director at Black Diamond Therapeutics, Inc., a Chief Executive Officer & Director at InduPro, Inc. and a President, Chief Executive Officer & Director at Ribon Therapeutics, Inc. He is on the Board of Directors at Olema Pharmaceuticals, Inc., Black Diamond Therapeutics, Inc., InduPro, Inc. and Ribon Therapeutics, Inc. Dr. Raman was previously employed as a VP & Global Head-NIBR Business Development by Novartis Institutes for Biomedical Research, Inc. and a Head-Project Management by AstraZeneca PLC.
He also served on the board at KSQ Therapeutics, Inc. and NAYA Therapeutics, Inc. He received his undergraduate degree from Indian Institute of Technology Bombay, a graduate degree from Indian Institute of Technology Bombay and a doctorate degree from the University of Wisconsin-Madison.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
26/06/2026 45,039 ( 0.08% ) 94 582 $ 31/08/2026
18/06/2026 0 ( -.--% ) - $ 31/08/2026

Prakash Raman active positions

CompaniesPositionStart
BLACK DIAMOND THERAPEUTICS, INC. Director/Board Member 10/04/2024
OLEMA PHARMACEUTICALS, INC. Director/Board Member 28/04/2026
Chief Executive Officer 17/02/2022
Indupro
Chief Executive Officer 13/06/2024
Chief Executive Officer 01/04/2024

Former positions of Prakash Raman

CompaniesPositionEnd
Corporate Officer/Principal 01/10/2019
ASTRAZENECA PLC Corporate Officer/Principal 01/11/2012
Chief Executive Officer -
See the detail of Prakash Raman's experience

Training of Prakash Raman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

71

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Indupro

Commercial Services

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!